COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 15, 2026 it granted stock options to purchase an aggregate of 21,220 shares of common [...]
AlkaLean Releases Updated 2026 Details About Its Natural GLP-1 Supplement Ingredient List with Baking Soda Recipe, Pricing, Refund Policy & Customer Service Support
17/07/2026
AlkaLean's Weight Management Formula Explained: Chicory Root Inulin, Potato Resistant Starch, and Probiotic Blend Dosages, Package Options, and Safety Guidance Largo, FL, July 17, 2026 (GLOBE NEWSWIRE) -- These [...]
Vaxart Announces Results of Annual Meeting of Stockholders
17/07/2026
SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based [...]
FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol
17/07/2026
First oral PCSK9 inhibitor provides an additional treatment option for adults with hypercholesterolemia Silver Spring, MD, July 17, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration approved Lipfendra ( [...]
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Immuneering Corporation Announces Grants of Inducement Awards
17/07/2026
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, previously announced on June [...]
4DMT Announces New Employment Inducement Grants
17/07/2026
EMERYVILLE, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases
17/07/2026
CHICAGO, July 17, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased an [...]
Report on Carbios’ liquidity contract
17/07/2026
REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716) / Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 17 July 2026 (18:00 CEST). CARBIOS , (Euronext Growth Paris: ALCRB [...]
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
17/07/2026
BOSTON, July 17, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple [...]
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
17/07/2026
Houston, Texas and Tuebingen, Germany, July 17, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell [...]
CARBIOS : Bilan semestriel du contrat de liquidité
17/07/2026
INFORMATION REGLEMENTEE : PERMANENTE Titre concerné : CARBIOS (code ISIN FR0011648716) / Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 17 juillet 2026 (18h00 CEST). CARBIOS présente le bilan [...]
Skyline LASIK Introduces WaveLight® Plus LASIK, Advancing Precision in Vision Correction
17/07/2026
New data presented at the American Academy of Ophthalmology highlights enhanced visual outcomes with next-generation LASIK technology Colorado Springs, CO, July 17, 2026 (GLOBE NEWSWIRE) -- Skyline LASIK is proud to [...]
Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients [...]
Sienna Announces Long-Term Care Redevelopment in Greater Toronto Area
17/07/2026
MARKHAM, Ontario, July 17, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it will proceed with its next redevelopment project in the Greater Toronto [...]
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
17/07/2026
Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in eliminating glioblastoma in preclinical studies. TAIPEI, TAIWAN, July 17, 2026 ( [...]
ACTG Announces Behavioral Health and Implementation Study to Optimize Long-Acting HIV Treatment among People who have Struggled to Maintain HIV Suppression
17/07/2026
CHAPEL HILL, N.C., July 17, 2026 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5432, a study assessing factors that may affect [...]
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
17/07/2026
Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands Amneal’s injectable contrast portfolio Portfolio now positioned to address the [...]
Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction
17/07/2026
Vancouver, Canada, July 17, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogenderived treatments for Alcohol Use Disorder [...]

Pages